• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOTICS, INC ADVIA CENTAUR XPT HBSAGII ASSAY; HBSII IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOTICS, INC ADVIA CENTAUR XPT HBSAGII ASSAY; HBSII IMMUNOASSAY Back to Search Results
Model Number N/A
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 05/12/2018
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The cause for the discordant (b)(6) results is unknown.Siemens has received samples for testing.The advia centaur/xp/xpt hbsagii information for use (ifu) states in the limitations section: "heterophilic antibodies in human serum can react with reagent immunoglobulins, interfering with in vitro immunoassays.Patients routinely exposed to animals or to animal serum products can be prone to this interference and anomalous values may be observed.Additional information may be required for diagnosis.For diagnostic purposes, the advia centaur hbsagii test results should always be assessed in conjunction with the patient's medical history, clinical examination, and other findings." the advia centaur/xp/xpt hbsagii information for use (ifu) states in the interpretation of results section: "samples with an index value of >/= 1.0 but
 
Event or Problem Description
The customer observed initial (b)(6) results that were (b)(6).(b)(6) results were not confirmed.Additional testing of the same sample and a subsequent sample from the same patient yielded (b)(6) results and not confirmed conf results.A previous (b)(6) result was (b)(6).The customer stated that a result of (b)(6) was reported to the physician.The patient is a dialysis patient.Based on the (b)(6) results, the patient was placed on a dialysis machine that is used for patient with (b)(6) results.There are no reports of adverse health consequences due to the (b)(6) results.The patient is now deceased due possible kidney failure.Mdr 1219913-2018-00174 is being filed for sample test results generated on may 15, 2018 for the same patient.
 
Additional Manufacturer Narrative
Siemens filed mdr 1219913-2018-00162 on june 14, 2018 reporting the observation of initial advia centaur xpt hbsagii results that were (b)(6) but did not confirm with the advia centaur xpt hbsagii confirmatory test.Mdr 1219913-2018-00174 was filed for sample test results generated on (b)(6) 2018 for the same patient.June 29, 2018 - additional information (b)(6).The advia centaur/xp/xpt hbsagii information for use (ifu) states in the limitations section: "heterophilic antibodies in human serum can react with reagent immunoglobulins, interfering with in vitro immunoassays.Patients routinely exposed to animals or to animal serum products can be prone to this interference and anomalous values may be observed.Additional information may be required for diagnosis.For diagnostic purposes, the advia centaur hbsagii test results should always be assessed in conjunction with the patient's medical history, clinical examination, and other findings." the results from the plasma samples did not confirm the results from the serum tube.No further investigation is required.Mdr 1219913-2018-00174 was filed for sample test results generated on (b)(6) 2018 for the same patient.Mdr 1219913-2018-00174 supplemental report 1 is filed with the results of siemens' testing as well.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XPT HBSAGII ASSAY
Common Device Name
HBSII IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOTICS, INC
511 benedict avenue
tarrytown NY 10591 5097
MDR Report Key7601615
Report Number1219913-2018-00162
Device Sequence Number19307241
Product Code LOM
UDI-Device Identifier00630414578170
UDI-Public00630414578170
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P030049
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source health professional,user faci
Initial Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date (Section B) 07/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/01/2019
Device Model NumberN/A
Device Catalogue Number10492138
Device Lot Number88321140
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer 05/17/2018
Supplement Date Received by Manufacturer06/29/2018
Initial Report FDA Received Date06/14/2018
Supplement Report FDA Received Date07/17/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-